| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Erratum
|
|
|
2000
|
21 |
4 |
p. 414-
1 p.
|
artikel
|
| 2 |
Estimating a Treatment Effect with the Accelerated Hazards Models
|
Chen, Ying Qing
|
|
2000
|
21 |
4 |
p. 369-380
12 p.
|
artikel
|
| 3 |
Estimating Significance Level and Power Comparisons for Testing Multiple Endpoints in Clinical Trials
|
Gong, Jianjian
|
|
2000
|
21 |
4 |
p. 313-329
17 p.
|
artikel
|
| 4 |
How to Select Covariates to Include in the Analysis of a Clinical Trial
|
Raab, Gillian M
|
|
2000
|
21 |
4 |
p. 330-342
13 p.
|
artikel
|
| 5 |
Letter from the editor
|
Neaton, James D
|
|
2000
|
21 |
4 |
p. 381-
1 p.
|
artikel
|
| 6 |
Letter to the editor
|
De Amici, D
|
|
2000
|
21 |
4 |
p. 381-382
2 p.
|
artikel
|
| 7 |
Multicenter Radial Artery Patency Study (RAPS)
|
|
|
2000
|
21 |
4 |
p. 397-413
17 p.
|
artikel
|
| 8 |
Phase II Clinical Trial Design for Noncytotoxic Anticancer Agents for Which Time to Disease Progression Is the Primary Endpoint
|
Mick, Rosemarie
|
|
2000
|
21 |
4 |
p. 343-359
17 p.
|
artikel
|
| 9 |
Power Calculation for Clinical Trials When the Outcome Is a Composite Ranking of Survival and a Nonfatal Outcome
|
McMahon, Robert P.
|
|
2000
|
21 |
4 |
p. 305-312
8 p.
|
artikel
|
| 10 |
The Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study
|
Lièvre, Michel
|
|
2000
|
21 |
4 |
p. 383-396
14 p.
|
artikel
|
| 11 |
The Phase II/III Transition
|
Fazzari, Melissa
|
|
2000
|
21 |
4 |
p. 360-368
9 p.
|
artikel
|
Tijdschrift beschrijving